Craig A Emter

The focus of my research is to understand the impact of novel pharmaceutical and exercise therapeutics on the myocardium and coronary arteries of the failing heart. Current research goals include elucidating new ways to treat both heart failure with preserved ejection fraction (HFpEF; a disease largely unresponsive to current standardized heart failure therapies) and heart failure with reduced ejection fraction (HFrEF) using pre-clinical swine models of heart failure.